Our expertise

There are currently human therapeutic antibodies approved for more than 40 different targets across a broad range of conditions that range from asthma to arthritis, and cancer to Crohn’s disease. For many of these conditions, dogs and cats get sick in just the same way, and the similarity is so high that the pet versions of these diseases are often studied to help us learn about the human illness.

PetMedix is using the experience of our founding team, as well as our network of advisors across the animal health world, to ensure that our pipeline of therapies targets the areas of biggest need where we can have the greatest impact. We are committed to ensuring that our strategy is based on robust science and solid commercial thinking.

Scroll to Top